Liao J - Search Results

1

Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.

Fan Q, Liao J, Kobayashi M, Yamashita M, Gu L, Gohda T, Suzuki Y, Wang LN, Horikoshi S, Tomino Y. Fan Q, et al. Among authors: liao j. Nephrol Dial Transplant. 2004 Dec;19(12):3012-20. doi: 10.1093/ndt/gfh499. Nephrol Dial Transplant. 2004. PMID: 15574998

2

Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.

Liao J, Kobayashi M, Kanamuru Y, Nakamura S, Makita Y, Funabiki K, Horikoshi S, Tomino Y. Liao J, et al. J Nephrol. 2003 Nov-Dec;16(6):841-9. J Nephrol. 2003. PMID: 14736011

3

Pathogenesis and treatment of type 2 diabetic nephropathy: lessons from the spontaneous KK/Ta mouse model.

Tomino Y, Tanimoto M, Shike T, Shiina K, Fan Q, Liao J, Gohda T, Makita Y, Funabiki K. Tomino Y, et al. Among authors: liao j. Curr Diabetes Rev. 2005 Aug;1(3):281-6. doi: 10.2174/157339905774574374. Curr Diabetes Rev. 2005. PMID: 18220604 Review.

4

Measurement of mouse urinary type IV collagen using time-resolved fluoroimmunoassay.

Kobayashi M, Kimura H, Liao J, Abe M, Hirose S, Tomino Y. Kobayashi M, et al. Among authors: liao j. Anal Sci. 2003 Feb;19(2):205-10. doi: 10.2116/analsci.19.205. Anal Sci. 2003. PMID: 12608746 Free article.

5

Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.

Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y. Zheng Y, et al. Among authors: liao j. J Nephrol. 2002 Jan-Feb;15(1):36-41. J Nephrol. 2002. PMID: 11936424

6

Effect of steroid-liposome on immunohistopathology of IgA nephropathy in ddY mice.

Liao J, Hayashi K, Horikoshi S, Ushijima H, Kimura J, Tomino Y. Liao J, et al. Nephron. 2001 Oct;89(2):194-200. doi: 10.1159/000046067. Nephron. 2001. PMID: 11549902

7

Determination of sensitivity and specificity of the Micral-Test II strip for detection of microalbuminuria in diabetic and nondiabetic patients.

Zheng YL, Liao J, Takeda Y, Io H, Kobata M, Kanamaru Y, Maeda A, Shou I, Igari J, Tomino Y. Zheng YL, et al. Among authors: liao j. Nephron. 1999;81(4):455. doi: 10.1159/000045338. Nephron. 1999. PMID: 10095190 Clinical Trial. No abstract available.

8

Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese zucker rats fed with an atherogenic diet.

Reisin E, Ebenezer PJ, Liao J, Lee BS, Larroque M, Hu X, Aguilar EA, Morse SA, Francis J. Reisin E, et al. Among authors: liao j. Am J Med Sci. 2009 Oct;338(4):301-9. doi: 10.1097/MAJ.0b013e3181b27195. Am J Med Sci. 2009. PMID: 19826320

9

Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats.

Liao J, Soltani Z, Ebenezer P, Isidro-Carrión AA, Zhang R, Asghar A, Aguilar E, Francis J, Hu X, Ferder L, Reisin E. Liao J, et al. Nephron Exp Nephrol. 2010;114(2):e61-8. doi: 10.1159/000254567. Epub 2009 Nov 4. Nephron Exp Nephrol. 2010. PMID: 19887847

10

Kidney disease and the metabolic syndrome.

Zhang R, Liao J, Morse S, Donelon S, Reisin E. Zhang R, et al. Among authors: liao j. Am J Med Sci. 2005 Dec;330(6):319-25. doi: 10.1097/00000441-200512000-00010. Am J Med Sci. 2005. PMID: 16355017 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,626 results

Search Page

Filters